Cargando…
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
OBJECTIVE: To determine whether a fraction of patients with primary CNS lymphoma (PCNSL) had been cured by systemic and intraventricular methotrexate- and cytarabine-based chemotherapy (Bonn protocol) after a very long-term follow-up of nearly 20 years. METHODS: Sixty-five patients (median age 62 ye...
Autores principales: | Seidel, Sabine, Pels, Hendrik, Schlömer, Sabine, Kowoll, Annika, Fliessbach, Klaus, Engert, Andreas, Vogt-Schaden, Marlies, Egerer, Gerlinde, Reichmann, Heinz, Schackert, Gabriele, Kroschinsky, Frank, Deckert, Martina, Herrlinger, Ulrich, Klockgether, Thomas, Fimmers, Rolf, Bode, Udo, Schmidt-Wolf, Ingo G.H., Schlegel, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734926/ https://www.ncbi.nlm.nih.gov/pubmed/32989105 http://dx.doi.org/10.1212/WNL.0000000000010949 |
Ejemplares similares
-
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
por: Patrij, Katrin, et al.
Publicado: (2011) -
Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma
por: Linnebank, M, et al.
Publicado: (2012) -
HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
por: Seidel, Sabine, et al.
Publicado: (2019) -
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma
por: Linnebank, M, et al.
Publicado: (2004) -
Physics at Bonn and Aix
Publicado: (1973)